CA933928A - Derives de la dihydro-3,4 isoquinoleine, leur preparation et les compositions medicinales qui les contiennent - Google Patents

Derives de la dihydro-3,4 isoquinoleine, leur preparation et les compositions medicinales qui les contiennent

Info

Publication number
CA933928A
CA933928A CA107530A CA107530A CA933928A CA 933928 A CA933928 A CA 933928A CA 107530 A CA107530 A CA 107530A CA 107530 A CA107530 A CA 107530A CA 933928 A CA933928 A CA 933928A
Authority
CA
Canada
Prior art keywords
les
isoquinoleine
medicinales
derives
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA107530A
Other languages
English (en)
Other versions
CA107530S (en
Inventor
Jeanmart Claude
N. Messer Mayer
Simon Pierre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc SA
Original Assignee
Rhone Poulenc SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc SA filed Critical Rhone Poulenc SA
Application granted granted Critical
Publication of CA933928A publication Critical patent/CA933928A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
CA107530A 1970-03-12 1971-03-11 Derives de la dihydro-3,4 isoquinoleine, leur preparation et les compositions medicinales qui les contiennent Expired CA933928A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR707008932A FR2081572B1 (no) 1970-03-12 1970-03-12

Publications (1)

Publication Number Publication Date
CA933928A true CA933928A (en) 1973-09-18

Family

ID=9052168

Family Applications (1)

Application Number Title Priority Date Filing Date
CA107530A Expired CA933928A (en) 1970-03-12 1971-03-11 Derives de la dihydro-3,4 isoquinoleine, leur preparation et les compositions medicinales qui les contiennent

Country Status (18)

Country Link
US (1) US3759924A (no)
JP (1) JPS5341156B1 (no)
AT (1) AT303042B (no)
BE (1) BE764133A (no)
CA (1) CA933928A (no)
CH (1) CH521347A (no)
DE (1) DE2112026C3 (no)
DK (1) DK126000B (no)
ES (1) ES389180A1 (no)
FI (1) FI49034C (no)
FR (1) FR2081572B1 (no)
GB (1) GB1285016A (no)
IE (1) IE35209B1 (no)
IL (1) IL36398A (no)
NL (1) NL7102897A (no)
NO (1) NO133400C (no)
SE (1) SE360655B (no)
ZA (1) ZA711602B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61109470U (no) * 1984-12-20 1986-07-11
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6291425B1 (en) * 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6346536B1 (en) 1997-09-03 2002-02-12 Guilford Pharmaceuticals Inc. Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US20020028813A1 (en) * 1997-09-03 2002-03-07 Paul F. Jackson Thioalkyl compounds, methods, and compositions for inhibiting parp activity
WO1999011622A1 (en) * 1997-09-03 1999-03-11 Guilford Pharmaceuticals Inc. Amino-substituted compounds, methods, and compositions for inhibiting parp activity
US6197785B1 (en) 1997-09-03 2001-03-06 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6514983B1 (en) 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
AU2001264595A1 (en) 2000-05-19 2001-12-03 Guilford Pharmaceuticals Inc. Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
US6348475B1 (en) 2000-06-01 2002-02-19 Guilford Pharmaceuticals Inc. Methods, compounds and compositions for treating gout
US6545011B2 (en) 2000-07-13 2003-04-08 Guilford Pharmaceuticals Inc. Substituted 4,9-dihydrocyclopenta[imn]phenanthridine-5-ones, derivatives thereof and their uses
CA3034994A1 (en) 2008-06-03 2009-12-10 Intermune, Inc. Substituted aryl-2 pyridone compounds and use thereof for treating inflammatory and fibrotic disorders
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
CN106459042B (zh) 2014-04-02 2019-06-28 英特穆恩公司 抗纤维化吡啶酮类

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3227085A (en) * 1963-09-05 1966-01-04 James L Ramer Shot shell
DE1670694B2 (de) * 1966-05-05 1976-07-22 Hoechst Ag, 6000 Frankfurt Verfahren zur herstellung von tetrahydroisochinolinen
FR1583755A (no) * 1968-03-06 1969-12-05
FR2028672A6 (no) * 1968-03-06 1970-10-16 Rhone Poulenc Sa
GB1244501A (en) * 1968-03-09 1971-09-02 Aspro Nicholas Ltd Heterocyclic amines

Also Published As

Publication number Publication date
DE2112026C3 (de) 1979-10-25
IL36398A (en) 1973-10-25
NO133400B (no) 1976-01-19
IL36398A0 (en) 1971-05-26
SE360655B (no) 1973-10-01
IE35209B1 (en) 1975-12-10
IE35209L (en) 1971-09-12
DK126000B (da) 1973-05-28
US3759924A (en) 1973-09-18
BE764133A (fr) 1971-09-13
JPS5341156B1 (no) 1978-10-31
NL7102897A (no) 1971-09-14
CH521347A (fr) 1972-04-15
AT303042B (de) 1972-11-10
ZA711602B (en) 1971-11-24
ES389180A1 (es) 1973-06-01
FR2081572B1 (no) 1973-04-06
FR2081572A1 (no) 1971-12-10
FI49034B (no) 1974-12-02
GB1285016A (en) 1972-08-09
DE2112026A1 (de) 1971-09-23
FI49034C (fi) 1975-03-10
DE2112026B2 (de) 1979-03-08
NO133400C (no) 1976-04-28

Similar Documents

Publication Publication Date Title
CA933928A (en) Derives de la dihydro-3,4 isoquinoleine, leur preparation et les compositions medicinales qui les contiennent
CA963470A (en) Derives de l'isoindoline, leur preparation et les compositions qui les contiennent
CA979890A (en) Derives d'acide adenosine -3',5'-phosphorique cyclique et leur preparation
CA981661A (en) Derives des polymyxines, leur preparation et les compositions medicinales les contenant
BE784286A (fr) Nouveaux derives de l'oxadiazolone, leur preparation et les compositions qui les contiennent
CA976549A (en) Derives de l'isoindoline, leur preparation et les compositions medicinales qui les contiennent
BE776682A (fr) Nouveaux derives de l'isoindoline, leur preparation et les compositionsmedicinales qui les contiennent
OA03835A (fr) Nouveaux dérivés de la thiazolidine, leur préparation et les compositions qui les contiennent.
CA980781A (en) Derives de la phenanthridine, leur preparation et les compositions medicinales qui les contiennent
CA963471A (en) Derives de la pyrrolo (3,4-b) pyridine, leur preparation et les compositions medicinales qui les contiennent
CA943553A (en) Derives de l'aminocarbonyl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique
CA940131A (en) Derives de l'imidazo (4,5 b) pyridine, leur preparation et les compositions qui les contiennent
CA961042A (en) Derives de l'isoindoline, leur preparation et les compositions medicinales qui les contiennent
CA985290A (en) Derives des acides phenylacetique et phenylpropionique, leur preparation et les compositions qui les contiennent
CA834192A (en) Derives de la dihydro-3,4 isoquinoleine et leur preparation
BE786583A (fr) Nouveaux derives de la phenothiazine, leur preparation et les compositions qui les contiennent
BE784287A (fr) Derives de l'oxadiazolone, leur preparation et les compositionsqui les contiennent
CA901584A (en) Derives du benzofuranne, leur preparation et les compositions medicinales qui les contiennent
BE765531A (fr) Nouveaux derives de 1'0-phenylene-diamine, leur preparation et les compositions qui les contiennent
CA837103A (en) Derives de la dibenzooxepinne et leur preparation
CA926867A (en) Esters de la dimethylsulfamoyl-3 hydroxyethyl-piperidinopropyl-10 phenothiazine, leur preparation et les compositions medicinales qui les contiennent
CA859728A (en) Derives de la dibenzazepine et leur preparation
BE770148A (fr) Nouveaux derives de la thiazolidine, leur preparation et les compositions qui les contiennent
CA843945A (en) Derives du dibenzocycloheptatriene et leur preparation
CA840434A (en) Derives du dibenzocycloheptadiene et leur preparation